ARTICLE | Clinical News
Protalix preclinical data
October 12, 2015 7:00 AM UTC
In an inflammatory mouse model, oral PRX-106 alleviated immune-mediated hepatitis and liver damage. Additionally, PRX-106 reduced liver necrosis and levels of interferon (IFN) gamma, alanine aminotra...